Antitrust Claims Over Patent Litigation Revived By 3rd Circuit

(September 8, 2016, 1:02 PM EDT) -- PHILADELPHIA — A Delaware federal judge erred in treating antitrust standing as an issue of subject matter jurisdiction in dismissing a putative class action against alleged supracompetitive pricing of medicated eye drops, the Third Circuit U.S. Court of Appeals ruled Sept. 7 (Hartig Drug Company Inc. v. Senju Pharmaceutical Co. Ltd., et al., No. 15-3289, 3rd Cir.; 2016 U.S. App. LEXIS 16404).

(Decision available. Document #16-160919-003Z.)

Accordingly, the appellate panel of Circuit Judges Thomas L. Ambro, Kent A. Jordan and Morton I. Greenberg reinstated claims by...
To view the full article, register now.